cbdMD Signs 2021 CrossFit Champion Justin Medeiros and Two-Time CrossFit Champion Annie Thorisdottir to Category Exclusive Partnerships

Also Joining Team cbdMD Are CrossFit Games Athletes Noah Ohlsen and Brent Fikowski

2021 CrossFit Games Champion, Justin Medeiros (Photo: Business Wire)

CHARLOTTE, N.C.--()--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, most highly trusted and recognized CBD companies, announced partnerships with four major CrossFit athletes in a bid to expand the company’s substantial footprint in the global fitness landscape. The athlete signings come on the heels of cbdMD’s successful activation as the Official CBD Partner of the 2021 NOBULL CrossFit Games in Madison, Wisconsin in July.

The signings include 2021 CrossFit Games champion Justin Medeiros and Annie Thorisdottir, the first women’s back-to-back champion (2011, 2012). The group also includes seven-time CrossFit Games qualifier and 2019 second-place finisher Noah Ohlsen, and Brent Fikowski, who qualified seven times and earned third place in 2021. According to the leading market research firm, Brightfield Group, nearly 20% of all CBD users consider themselves “fitness fanatics” and regularly focus on working out as a way to support their mental and physical health.

“I was personally inspired by the athletes on Team cbdMD. I’m excited to do my part to help CrossFit athletes, and people in all sports and fitness arenas, better understand how cbdMD can support them in all things they do to get fit and stay healthy,” said 2021 NOBULL CrossFit Games champion, Justin Medeiros.

“cbdMD has unequivocally built a  ‘brand of champions,’ signing the best athletes in the world within numerous categories representing cbdMD’s superlative products. The addition of the CrossFit Games’ World Champions Justin Medeiros and Annie Thorisdottir, along with powerhouse competitors Brent Fikowski and Noah Ohlsen, further cements the brand’s dominance within athletics. Their global footprint and endorsement of cbdMD will vastly help elevate the use, benefits, and education of CBD in the CrossFit community,” said Hans Molenkamp, Executive Vice President of Sports Marketing at cbdMD, Inc.

As brand ambassadors, the cadre of athletes will reach over three million followers on Instagram alone, extending cbdMD’s market penetration into CrossFit’s worldwide ecosystem of 15,000 affiliated gyms across 120 countries with four million members.

“These incredible athletes are the perfect examples of what people can achieve when they commit to a lifestyle that centers around health and fitness. They made the choice to push past barriers and obstacles to become something greater. They are all professional athletes in their own right. As a brand, cbdMD encourages this kind of dedication, and the products we offer are custom-built to help people from all walks of life reach their goals, no matter what they want to achieve. As ambassadors for cbdMD, these athletes will help inspire millions to rise above personal obstacles to enjoy a higher quality, more fulfilling life,” said Martin A. Sumichrast, Chairman & Co-CEO of cbdMD, Inc.

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products. Our cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes. Our Paw CBD brand of pet products includes over 45 SKUs of products including tinctures, chews, topicals products in varying strengths, and our CBD Botanicals brand of beauty and skincare products features 15 SKUs, including facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care. To learn more about cbdMD and their comprehensive line of U.S. grown, THC-free1 CBD oil products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2020 as filed with the Securities and Exchange Commission (the "SEC") on December 22, 2020 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

1THC-free is defined as below the level of detection using validated scientific analytical tools.

Contacts

PR:
cbdMD, Inc.
Robert Pettway
Director of Digital Marketing
rpettway@cbdmd.com
(423) 503-5225

Investors:
cbdMD, Inc.
John Weston
Director of Investor Relations
john.weston@cbdmd.com
(704) 249-9515

Contacts

PR:
cbdMD, Inc.
Robert Pettway
Director of Digital Marketing
rpettway@cbdmd.com
(423) 503-5225

Investors:
cbdMD, Inc.
John Weston
Director of Investor Relations
john.weston@cbdmd.com
(704) 249-9515